CLEVELAND, Aug. 13, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Dartmouth-Hitchcock Health in New Hampshire has begun patient treatments with the MRIdian® MRI-Guided Therapy ...

CLEVELAND, Jan. 26, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that Henry Ford Cancer Institute has installed its second MRIdian Linac at its new cancer pavilion, Henry Ford ...

CLEVELAND, Feb. 4, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Edogawa Hospital in Tokyo is the first hospital in Japan to treat patients with the MRIdian Linac System.

CLEVELAND, Aug. 5, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) in Kaohsiung City, Taiwan has begun patient ...

CLEVELAND, Aug. 11, 2022 /PRNewswire/ -- ViewRay, Inc. (MRXC) (NASDAQ: VRAY) today announced that the National Cancer Center Hospital (NCCH) of Japan has upgraded its original Cobalt MRIdian® ...

ViewRay's MRIdian Linac system received FDA approval in February 2017. The company's system has received positive reviews from oncologists and hospitals. We view its new system as a game changer in ...

The market introduction of the MR-Linac technology improves the patient care via the real-time imaging of the targeted PTVs. Conventional Water Phantoms with ferromagnetic material become prohibited ...

Viewray Inc. received FDA clearance for the Mridian Linac system, a device that allows clinicians to visualize in real time the movement of tumors and organs during radiation treatment. The Oakwood, ...

The market introduction of the MR-Linac technology improves the quality of patient care via the real-time imaging of the targeted PTVs. The online control of the PTVs permits the gating process of the ...